HEOR

News

The word Diabetes surrounded by tablets and syringes

NICE backs changes to NHS' diabetes care pathway

New guidance from NICE on type 2 diabetes management will shake up NHS treatment, with wider use of both SGLT2 inhibitors and GLP-1 agonists.

News

NICE backs first disease-modifying drug for ARG1 deficiency

Immedica's Loargys is poised to become the first NHS therapy for ultra-rare genetic disorder ARG1 deficiency that can alter the course of the disease.

News

Abbott's wireless heart failure sensor cleared for NHS use

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.

News

COPD patients will get access to Dupixent via NHS

Almost 30,000 people in England with COPD stand to get access to Dupixent, the first biologic for the devastating disease, after NICE backs its use.

News

Change of heart as NICE backs prostate cancer drug Talzenna

Thousands of men with prostate cancer will be offered a new treatment, Pfizer's Talzenna, after NICE made an about-turn on the drug.

News

NICE backs Roche lupus drug that supports kidney function

Roche's Gazyvaro, a drug that can restore kidney function in lupus nephritis, has been cleared for use by the NHS in England and Wales.

NICE backs changes to NHS' diabetes care pathway

NICE backs first disease-modifying drug for ARG1 deficiency

Abbott's wireless heart failure sensor cleared for NHS use

COPD patients will get access to Dupixent via NHS

Change of heart as NICE backs prostate cancer drug Talzenna

NICE backs Roche lupus drug that supports kidney function

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

HEOR

Editor's Picks